MBIO
Mustang Bio·NASDAQ
--
--(--)
--
--(--)
MBIO fundamentals
Mustang Bio (MBIO) expects to report earnings on Nov 8, 2024, with estimated revenue of 0 (YoY --), and EPS at -6.5 (YoY +89.43%).
Revenue estimate / YoY
0
--
EPS estimate / YoY
-6.5
+89.43%
Report date
Nov 8, 2024
EPS
Actual | -210 | -240 | -172.5 | -232.5 | -142.5 | -120 | -142.5 | -165 | -150 | -142.5 | -135 | -135 | -103 | -100 | -61.5 | -35.5 | -23 | -17.5 | ||||||||||
Forecast | -230 | -200 | -187.5 | -155.625 | -140 | -145.5 | -135.195 | -144 | -138 | -156 | -148.125 | -142.5 | -150.5 | -90.375 | -63.75 | -77.8333 | -43.5 | -7 | -6.5 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +8.70% | -20.00% | +8.00% | -49.40% | -1.79% | +17.53% | -5.40% | -14.58% | -8.70% | +8.65% | +8.86% | +5.26% | +31.56% | -10.65% | +3.53% | +54.39% | +47.13% | -150.00% | 0.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -- |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Mustang Bio next quarter?What is Mustang Bio's latest dividend and current dividend yield?What were the key takeaways from Mustang Bio’s earnings call?What factors drove the changes in Mustang Bio's revenue and profit?What guidance did Mustang Bio's management provide for the next earnings period?What is the revenue and EPS growth rate for Mustang Bio year over year?What is Mustang Bio's gross profit margin?Did Mustang Bio beat or miss consensus estimates last quarter?
